Back to search

Georgia Institute of Technology

Process development and process analytical technology integration for cell therapy manufacturing

Abstract

dc:description.abstract

Biomanufacturing of cell therapies involves highly complex and labor-intensive processes, where the process parameters and biological variabilities can significantly influence product quality, reproducibility, and therapeutic efficacy of the products. The complexity and largely manual unit operations contribute to product variability and high cost. To address these manufacturing challenges, we designed a digital-twin-enabled closed-loop cell manufacturing platform with automation and feedback controls. This platform integrates process analytical technologies (PAT) to enable deeper process understanding and provide real-time control of process variables. Specifically, we designed bench-scale bioreactors with automated sampling, at-line and in-line monitoring, digital twin-enabled media nutrients estimation, and feedback-controlled feeding capabilities. Human umbilical cord tissue-derived MSCs (CT-MSCs) and T cells were used as the example cell therapy product. At-line glucose and lactate monitoring confirmed the accuracy of the digital twin estimations. Spent media samples and detailed functional characterizations of the MSCs and T cells end-products generated from the automation-controlled bioreactor demonstrated that high expansion and functions of the MSCs and T cells were maintained in these closed-loop bioreactors. Real-time imaging with quantitative oblique back illumination microscopy showed high-resolution images of cells in-process in a dynamic 3D environment. Overall, the digital twin-enabled bioreactor platform reduced costs, labor, time, and, more importantly, perturbations; and could improve yield while maintaining the phenotype and quality of cell therapy products. Our integrated automation system provides a blueprint for multiplexed PAT integration, process optimization, feedback-controlled intelligent automation to enable the discovery, monitoring, and control of critical quality attributes and critical process parameters for cell therapy manufacturing.

Degree

thesis:*
Level thesis:degree_level
Doctoral
Department dc:contributor.department
Chemical and Biomolecular Engineering
Grantor dc:publisher
Georgia Institute of Technology
Year dc:date.issued
2023

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Wang, Bryan
Advisor dc:contributor.advisor
  • Roy, Krishnendu
Committee members dc:contributor.committeemember
  • Yeago, Carolyn
  • Boukuvala, Fani
  • Temenoff, Johnna
  • Balakirsky, Stephen

Subjects

dc:subject × 5

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/1853/76777

Chain of custody

source
Harvested from
Georgia Tech
Base URL
repository.gatech.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Wang, Bryan. Process development and process analytical technology integration for cell therapy manufacturing. Doctoral thesis, Georgia Institute of Technology, 2023. https://hdl.handle.net/1853/76777